These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 3092113
1. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Philip R, Epstein LB. Nature; ; 323(6083):86-9. PubMed ID: 3092113 [Abstract] [Full Text] [Related]
2. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages. Hori K, Mihich E, Ehrke MJ. Cancer Res; 1989 May 15; 49(10):2606-14. PubMed ID: 2496917 [Abstract] [Full Text] [Related]
3. Lipopolysaccharide and interleukin 1 inhibit interferon-gamma-induced Fc receptor expression on human monocytes. Arend WP, Ammons JT, Kotzin BL. J Immunol; 1987 Sep 15; 139(6):1873-9. PubMed ID: 2957441 [Abstract] [Full Text] [Related]
4. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity. Webb DS, Gerrard TL. J Immunol; 1990 May 01; 144(9):3643-8. PubMed ID: 2158515 [Abstract] [Full Text] [Related]
5. Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-gamma and IL-4. Takashima T, Ohnishi K, Tsuyuguchi I, Kishimoto S. J Immunol; 1993 Apr 01; 150(7):3002-10. PubMed ID: 8454870 [Abstract] [Full Text] [Related]
6. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells. Frey JR, Kamber M, Peck R. Lymphokine Res; 1987 Apr 01; 6(3):215-27. PubMed ID: 3114569 [Abstract] [Full Text] [Related]
7. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. Kornbluth RS, Edgington TS. J Immunol; 1986 Oct 15; 137(8):2585-91. PubMed ID: 3760568 [Abstract] [Full Text] [Related]
8. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha. van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG, Langenhuijsen MM. Exp Hematol; 1993 Mar 15; 21(3):461-8. PubMed ID: 8440344 [Abstract] [Full Text] [Related]
9. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production. Konur A, Schulz U, Eissner G, Andreesen R, Holler E. Br J Dermatol; 2005 Jun 15; 152(6):1134-42. PubMed ID: 15948973 [Abstract] [Full Text] [Related]
10. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma. Minty A, Ferrara P, Caput D. Eur Cytokine Netw; 1997 Jun 15; 8(2):189-201. PubMed ID: 9262968 [Abstract] [Full Text] [Related]
11. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes. Nissen-Meyer J, Hofsli E, Espevik T, Austgulen R. Nat Immun Cell Growth Regul; 1988 Jun 15; 7(5-6):266-79. PubMed ID: 3146697 [Abstract] [Full Text] [Related]
12. Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF. Philip R. J Immunol; 1988 Feb 15; 140(4):1345-9. PubMed ID: 2449501 [Abstract] [Full Text] [Related]
13. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes. Joyce DA, Steer JH. Cytokine; 1996 Jan 15; 8(1):49-57. PubMed ID: 8742066 [Abstract] [Full Text] [Related]
14. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity. Onozaki K, Matsushima K, Kleinerman ES, Saito T, Oppenheim JJ. J Immunol; 1985 Jul 15; 135(1):314-20. PubMed ID: 3873493 [Abstract] [Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. Bundschuh DS, Barsig J, Hartung T, Randow F, Döcke WD, Volk HD, Wendel A. J Immunol; 1997 Mar 15; 158(6):2862-71. PubMed ID: 9058823 [Abstract] [Full Text] [Related]
16. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. Feinman R, Henriksen-DeStefano D, Tsujimoto M, Vilcek J. J Immunol; 1987 Jan 15; 138(2):635-40. PubMed ID: 3098851 [Abstract] [Full Text] [Related]
17. Coordinated induction of autocrine tumor necrosis factor and interleukin 1 in normal human monocytes and the implications for monocyte-mediated cytotoxicity. Smith DM, Lackides GA, Epstein LB. Cancer Res; 1990 Jun 01; 50(11):3146-53. PubMed ID: 2334910 [Abstract] [Full Text] [Related]
18. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. Sampson-Johannes A, Carlino JA. J Immunol; 1988 Nov 15; 141(10):3680-6. PubMed ID: 3053901 [Abstract] [Full Text] [Related]
19. Cytotoxicity of activated monocytes on endothelial cells. Peri G, Chiaffarino F, Bernasconi S, Padura IM, Mantovani A. J Immunol; 1990 Feb 15; 144(4):1444-8. PubMed ID: 2137492 [Abstract] [Full Text] [Related]
20. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both. Ichinose Y, Bakouche O, Tsao JY, Fidler IJ. J Immunol; 1988 Jul 15; 141(2):512-8. PubMed ID: 3260254 [Abstract] [Full Text] [Related] Page: [Next] [New Search]